Monday, June 27, 2022

Kolkata-based Das family pins hope on crowdfunding to raise INR 16 crores for their son’s SMA treatment

Date:

Kolkata-based Das family is raising funds through the crowdfunding platform ImpactGuru.com for their 4-month-old son Ayush Das who is suffering from SMA Type 1 (Spinal Muscular Atrophy). He is fighting against this deadly disease which is affecting him from doing basic activities like moving, eating, breathing, and swallowing and is also slowly corrupting his muscles. Ayush is currently raising funds of INR 16 crores through the crowdfunding platform for his Zolgensma therapy. So far, Ayush’s ImpactGuru fundraiser has raised over Rs. 5 lakhs in the span of 7 days.

Ayush’s father, Arpon Das is a government job employee while his wife is also a working professional in a private company. Ayush’s parents are trying their best to save his life by giving him the complete and best treatment. However, the huge amount of INR 16 Crores stands as the biggest obstacle in their endless efforts. Seeing little Ayush suffer from this deadly disease every second, breaks the heart of his family. Currently, he is in very critical condition and undergoing treatment at Peerless Hospital, Kolkata.

We are on a mission to give my baby a normal and healthy life which could be achieved with the life-saving drug Zolgensma a gene therapy medicine for treating spinal muscular atrophy. Ayush has been a strong warrior so far and has survived all the pain that life throws at it. However, as parents it is like walking on shattered pieces of glasses everyday while we see our little one suffer” says Arpon, Ayush’s Father

SMA is a progressive neuromuscular disease caused due to defects in the SMN1 gene. The affected children develop muscle weakness involving upper and lower limbs initially, but over time develop breathing difficulty and swallowing difficulty. SMA affects 1 in 10,000 children generally, and there are nearly 800 children suffering from SMA in India currently, and thrice as many children die before they even reach their 2nd birthday. The best treatment available for SMA is Zolgensma, an American gene therapy replacement drug, carrying a duplicate copy of SMN1 protein. One shot of Zolgensma infused in the vein of a child below 2 years of age has the potential to stop the rapid clock of muscle atrophy (weakening and shrinking) in the body and restore the lost functions over time.

“My little angel and all my hope are now in your hands. We desperately need your help to save my child. He is too small to be facing the challenges of this lethal disease and my heart is shattering by realizing the failure of not being able to afford the treatment. For you, it will be a donation but for Ayush, it will be a rebirth. Even the tiniest of your contributions through the ImpactGuru platform can immensely help us.” appeals Arpon.

Fundraiser Link: https://www.impactguru.com/fundraiser/support-baby-ayush

Share post:

More like this
Related

Techno India Group Hosts ‘Rooh-e-Ghazal’

Techno India Group, the largest private education group in...

ExxonMobil Super Parivartan – launches next-gen Mobil Super range of lubricants in new, improved packaging

ExxonMobil Lubricants Pvt Ltd today announced the launch of its...

5TH ANNUAL CHARLES CORREA MEMORIAL LECTURE ORGANIZED BY AMBUJA NEOTIA GROUP

The 5th edition of the Charles Correa Memorial Lecture was...

The magical combination to pamper your skin this monsoon – Neem and Aloe Vera

 The monsoons are incoming and with it comes the...
THE TIMES OF BENGAL